
    
      Individuals will be identified for participation based upon baseline laboratory values
      obtained at the local Community Mental Health Clinic (CMHC) as part of the standard
      monitoring procedures for individuals on Second Generation Antipsychotics (SGAs). Following
      randomization, a research assistant will be assigned to obtain information on primary care
      provider visits, medications and lab tests conducted outside of the CMHC using a signed
      release for from the patient. Variables collected include: date and time of all physician or
      practitioner visits, type of practitioner, all medication prescriptions, and all laboratory
      values and vital signs related to metabolic syndrome parameters. Data will be put into an
      access data base for analysis. Data from private pharmacies will be obtained using a separate
      signed consent form.
    
  